RG Trademark

Trademark Overview


On Tuesday, August 24, 2021, a trademark application was filed for RG with the United States Patent and Trademark Office. The USPTO has given the RG trademark a serial number of 90898577. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Wednesday, May 8, 2024. This trademark is owned by RinuaGene Biotechnology Co., Ltd.. The RG trademark is filed in the Chemical Products category with the following description:

Biochemicals, namely, proteins, protein-encoding nucleic acids, polypeptide-encoding nucleic acids and polypeptides for use in vivo, ex vivo, on vivo or in vitro scientific research and medical research, and for use in the manufacture of food or nutritional supplements; biochemicals, namely, proteins, protein-encoding nucleic acids, polypeptide-encoding nucleic acids and polypeptides for use in the manufacture of pharmaceuticals for treating rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders and reproductive disorders; active chemical ingredients for use in manufacture of biotherapeutics, biosimilars and therapeutics products for treating infectious diseases and cancer; chemicals for use in biotherapeutics, biosimilars and therapeutics product development and manufacturing processes; adjuvants for use in manufacture of vaccines; reagents for testing sterility of pharmace...
rg

General Information


Serial Number90898577
Word MarkRG
Filing DateTuesday, August 24, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateWednesday, May 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 23, 2022

Trademark Statements


Description of MarkThe mark consists of a stylized illustration of the letters "R" and "G", which illustration is also meant to be a stylized presentation of the DNA double helix structure.
Goods and ServicesBiochemicals, namely, proteins, protein-encoding nucleic acids, polypeptide-encoding nucleic acids and polypeptides for use in vivo, ex vivo, on vivo or in vitro scientific research and medical research, and for use in the manufacture of food or nutritional supplements; biochemicals, namely, proteins, protein-encoding nucleic acids, polypeptide-encoding nucleic acids and polypeptides for use in the manufacture of pharmaceuticals for treating rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders and reproductive disorders; active chemical ingredients for use in manufacture of biotherapeutics, biosimilars and therapeutics products for treating infectious diseases and cancer; chemicals for use in biotherapeutics, biosimilars and therapeutics product development and manufacturing processes; adjuvants for use in manufacture of vaccines; reagents for testing sterility of pharmaceuticals; protein arrays and nucleotide arrays for scientific and medical laboratory use for scientific and medical research; nucleic acids, proteins and peptides for laboratory use; diagnostic preparations for clinical or medical laboratory use; diagnostic preparations for scientific or research use other than for medical purposes

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateSunday, October 10, 2021
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRinuaGene Biotechnology Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSuzhou, Jiangsu 215000
CN

Party NameRinuaGene Biotechnology Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSuzhou, Jiangsu 215000
CN

Trademark Events


Event DateEvent Description
Friday, August 27, 2021NEW APPLICATION ENTERED
Sunday, October 10, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 12, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, May 26, 2022ASSIGNED TO EXAMINER
Thursday, June 9, 2022NON-FINAL ACTION WRITTEN
Thursday, June 9, 2022NON-FINAL ACTION E-MAILED
Thursday, June 9, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 15, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Friday, July 15, 2022WITHDRAWAL OF ATTORNEY GRANTED
Friday, July 15, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 15, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 15, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 15, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 18, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 3, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 23, 2022PUBLISHED FOR OPPOSITION
Tuesday, August 23, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 18, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 20, 2023SOU TEAS EXTENSION RECEIVED
Monday, March 20, 2023SOU EXTENSION 1 FILED
Monday, March 20, 2023SOU EXTENSION 1 GRANTED
Monday, March 20, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 20, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 20, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 17, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, April 17, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 17, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, October 4, 2023ASSIGNED TO EXAMINER
Wednesday, October 11, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, October 11, 2023SOU EXTENSION 2 FILED
Wednesday, October 11, 2023SOU EXTENSION 2 GRANTED
Friday, October 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 12, 2024SOU EXTENSION 3 FILED
Friday, April 12, 2024DIVISIONAL REQUEST RECEIVED
Friday, April 12, 2024SOU TEAS EXTENSION RECEIVED
Friday, April 12, 2024TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, April 23, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 8, 2024SOU EXTENSION 3 GRANTED
Wednesday, May 8, 2024DIVISIONAL PROCESSING COMPLETE
Thursday, May 9, 2024CORRECTED NOA E-MAILED
Thursday, May 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED